HK1000890A1 - Antitumor indolopyrolocarbazole derivative - Google Patents

Antitumor indolopyrolocarbazole derivative Download PDF

Info

Publication number
HK1000890A1
HK1000890A1 HK97102485A HK97102485A HK1000890A1 HK 1000890 A1 HK1000890 A1 HK 1000890A1 HK 97102485 A HK97102485 A HK 97102485A HK 97102485 A HK97102485 A HK 97102485A HK 1000890 A1 HK1000890 A1 HK 1000890A1
Authority
HK
Hong Kong
Prior art keywords
formula
compound
compound represented
group
bits
Prior art date
Application number
HK97102485A
Other languages
English (en)
Chinese (zh)
Other versions
HK1000890B (en
Inventor
小尻胜久
近藤久雄
荒川浩治
大久保满
须田宽之
Original Assignee
万有制药株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 万有制药株式会社 filed Critical 万有制药株式会社
Priority claimed from PCT/JP1995/000868 external-priority patent/WO1995030682A1/ja
Publication of HK1000890B publication Critical patent/HK1000890B/xx
Publication of HK1000890A1 publication Critical patent/HK1000890A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/16—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
HK97102485A 1994-05-09 1995-05-02 Antitumor indolopyrolocarbazole derivative HK1000890A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP119483/94 1994-05-09
JP11948394 1994-05-09
JP145648/94 1994-06-03
JP14564894 1994-06-03
PCT/JP1995/000868 WO1995030682A1 (en) 1994-05-09 1995-05-02 Antitumor indolopyprolocarbazole derivative

Publications (2)

Publication Number Publication Date
HK1000890B HK1000890B (en) 2004-01-09
HK1000890A1 true HK1000890A1 (en) 2004-01-09

Family

ID=26457215

Family Applications (1)

Application Number Title Priority Date Filing Date
HK97102485A HK1000890A1 (en) 1994-05-09 1995-05-02 Antitumor indolopyrolocarbazole derivative

Country Status (14)

Country Link
EP (2) EP0760375B1 (enExample)
JP (1) JP3038921B2 (enExample)
KR (1) KR100312473B1 (enExample)
CN (2) CN1285605C (enExample)
AT (2) ATE283863T1 (enExample)
AU (1) AU683749B2 (enExample)
CA (1) CA2190007C (enExample)
CL (1) CL2004001117A1 (enExample)
DE (2) DE69533833T2 (enExample)
DK (2) DK1264836T3 (enExample)
ES (2) ES2230433T3 (enExample)
HK (1) HK1000890A1 (enExample)
PT (2) PT760375E (enExample)
TW (1) TW313566B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050058444A (ko) * 2002-08-23 2005-06-16 반유 세이야꾸 가부시끼가이샤 인돌로피롤로카르바졸 유도체의 제조법
CN101585861B (zh) * 2009-07-03 2012-10-24 复旦大学 N-糖基萘并咔唑化合物及其合成方法和应用
WO2025082431A1 (zh) * 2023-10-18 2025-04-24 正大天晴药业集团股份有限公司 一种吲哚衍生物治疗头颈部肿瘤的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
EP0528030B1 (en) * 1990-05-11 1997-09-17 Banyu Pharmaceutical Co., Ltd. Antitumor be-13793c derivative
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
JP3707075B2 (ja) * 1994-06-13 2005-10-19 萬有製薬株式会社 グリコシルトランスフェラーゼをコードする遺伝子及びその用途
AU3086495A (en) * 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles

Also Published As

Publication number Publication date
ES2206501T3 (es) 2004-05-16
CL2004001117A1 (es) 2005-04-22
AU683749B2 (en) 1997-11-20
DK0760375T3 (da) 2003-12-29
DE69532198T2 (de) 2004-08-26
JP3038921B2 (ja) 2000-05-08
ATE255121T1 (de) 2003-12-15
DE69533833T2 (de) 2005-12-15
KR970702869A (ko) 1997-06-10
EP0760375A4 (en) 2002-03-27
PT760375E (pt) 2004-04-30
EP1264836B1 (en) 2004-12-01
CN1106400C (zh) 2003-04-23
CN1285605C (zh) 2006-11-22
TW313566B (enExample) 1997-08-21
PT1264836E (pt) 2005-02-28
DE69532198D1 (de) 2004-01-08
EP1264836A1 (en) 2002-12-11
DE69533833D1 (de) 2005-01-05
CN1153518A (zh) 1997-07-02
DK1264836T3 (da) 2005-03-07
CN1513865A (zh) 2004-07-21
CA2190007A1 (en) 1995-11-16
EP0760375B1 (en) 2003-11-26
CA2190007C (en) 2003-04-15
ES2230433T3 (es) 2005-05-01
AU2353595A (en) 1995-11-29
KR100312473B1 (ko) 2002-06-24
HK1067948A1 (en) 2005-04-22
EP0760375A1 (en) 1997-03-05
ATE283863T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
CN1097054C (zh) 三环类吡唑衍生物及其组合物
CN87107928A (zh) 利拜卡霉素类似物
CN1035117A (zh) 2′，3′-二脱氧-2′，2′-二氟核苷的制备方法
CN1045395A (zh) 2′-脱氧-5-氟尿苷衍生物和其制法
CN1090634C (zh) 喜树碱的前药形式和类似物,及其药物用途
CN1495182A (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CN1047866A (zh) N-杂芳基-嘌呤-6-胺的制备方法及其药用
US5922860A (en) Antitumor indolopyrrolocarbazole derivatives
CN1126723A (zh) 4-脱氧-4-表鬼臼毒素衍生物的制备方法
CN1024922C (zh) 制备阿霉素的吗啉基衍生物的改进方法
WO1995030682A1 (en) Antitumor indolopyprolocarbazole derivative
US5804564A (en) Antitumor indolopyrrolocarbazole derivatives
CN1106400C (zh) 抗肿瘤吲哚并吡咯并咔唑衍生物
HK1000890B (en) Antitumor indolopyrolocarbazole derivative
CN1203074C (zh) 五环紫杉烷化合物
CN1252788A (zh) 制备药用化合物的方法
CN1301701A (zh) 喜树碱类似物化合物,其制备方法及含有它们的药物组合物
CN1468240A (zh) variolin B的衍生物
HK1046280A1 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-derivatives
HK1049159A1 (en) New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them
JPWO1995030682A1 (ja) 抗腫瘍性インドロピロロカルバゾール誘導体
CN1172476A (zh) 丙烯酮衍生物
HK1067948B (zh) 抗肿瘤吲哚并吡咯并咔唑衍生物
CN1122669C (zh) 8H－噻吩并[2，3－b]吡咯嗪－8－酮化合物，其制备方法以及含有它们的药物组合物
CN1082026A (zh) 2-[n-取代胺烷基]-5-(e)-烷亚甲基或苯亚甲基环戊酮衍生物及有关使用方法

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100502